# Novagali Pharma

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/novagali-pharma

- Industry: Pharmaceuticals
- Headquarters: France
- Website: www.novagali.com
- Total disclosed funding: $43M
- Latest round: Series D (Dec 1, 2008)
- Investors on record: 7

## About

Novagali Pharma SA is a pharmaceutical company focused on developing innovative eye care products to enhance patient treatment experiences and outcomes.Novagali Pharma SA specializes in ophthalmic products, with its headquarters located in France. Founded in 2000, the company completed an IPO in July 2010, raising EUR 22.00 mn. In October 2011, Novagali Pharma was acquired by Santen Pharmaceutical. The CEO is Damien Salauze, who leads the company following its strategic developments and financial rounds.Novagali Pharma SA develops a range of eye care solutions, focusing on treatments for various ocular conditions. The company aims to improve the delivery of therapeutic agents through its innovative formulations, which cater to diverse patient needs in the ophthalmology sector.In the most recent fiscal year of 2024, Novagali Pharma reported a revenue of EUR 46,122,398.90, with an EBITDA of EUR 27,160,421.60, indicating a solid financial performance in the pharmaceutical sector.Moving forward, Novagali Pharma SA is focused on launching new ophthalmic products designed to address unmet medical needs. The company is exploring expansion into key European markets and aims to leverage recent funding from its IPO to support research and development in product innovation. The successful completion of its IPO in July 2010 for EUR 22 mn will facilitate these strategic initiatives.

## Funding rounds

- Series D, Dec 1, 2008, $22M — Auriga Partners, Siparex, CDC Enterprises, Andera Partners, Crédit Agricole Asset Management Capital Investors
- Series B, Sep 21, 2004, $11M — Auriga Partners, Siparex, CDC Enterprises, Andera Partners, Crédit Agricole Asset Management Capital Investors
- Series B, Nov 1, 2003, $5.8M — 123 Investment Managers, Auriga Partners, CDC Enterprises, Crédit Agricole Asset Management Capital Investors
- Series A, Jun 1, 2000, $3.6M — Auriga Partners, CDC Corporation

## Investors

- Auriga Partners (https://capitalatlas.ai/funds/auriga-partners) — Series A, Series B, Series D
- CDC Corporation (https://capitalatlas.ai/funds/cdc-corporation) — Series A
- 123 Investment Managers (https://capitalatlas.ai/funds/123-investment-managers) — Series B
- CDC Enterprises (https://capitalatlas.ai/funds/cdc-enterprises) — Series B, Series D
- Crédit Agricole Asset Management Capital Investors (https://capitalatlas.ai/funds/credit-agricole-asset-management-capital-investors) — Series B, Series D
- Siparex (https://capitalatlas.ai/funds/siparex) — Series B, Series D
- Andera Partners (https://capitalatlas.ai/funds/andera-partners) — Series B, Series D